Literature DB >> 27899010

New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.

David S Pisetsky1, Brad H Rovin2, Peter E Lipsky3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27899010     DOI： 10.1002/art.40008

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  12 in total

1.  Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.

Authors:  M Frodlund; J Wetterö; C Dahle; Ö Dahlström; T Skogh; J Rönnelid; C Sjöwall
Journal:  Clin Exp Immunol       Date:  2019-12-19       Impact factor: 4.330

2.  DNA-nanoparticle interactions: Formation of a DNA corona and its effects on a protein corona.

Authors:  Darbi M Griffith; Dhanya T Jayaram; Diane M Spencer; David S Pisetsky; Christine K Payne
Journal:  Biointerphases       Date:  2020-10-01       Impact factor: 2.456

3.  The SLE-key test serological signature: new insights into the course of lupus.

Authors:  Chaim Putterman; David S Pisetsky; Michelle Petri; Roberto Caricchio; Alan H B Wu; Ignacio Sanz; Jim C Oates; Steve Wallace; Rachel Sorek; Robert Gerwien; Pennina Safer; Keren Jakobi-Brook; Irun R Cohen
Journal:  Rheumatology (Oxford)       Date:  2018-09-01       Impact factor: 7.580

Review 4.  Evolving story of autoantibodies in systemic lupus erythematosus.

Authors:  David S Pisetsky
Journal:  J Autoimmun       Date:  2019-12-04       Impact factor: 7.094

Review 5.  Differentiating between UCTD and early-stage SLE: from definitions to clinical approach.

Authors:  Savino Sciascia; Dario Roccatello; Massimo Radin; Ioannis Parodis; Jinoos Yazdany; Guillermo Pons-Estel; Marta Mosca
Journal:  Nat Rev Rheumatol       Date:  2021-11-11       Impact factor: 20.543

6.  Precipitating anti-dsDNA peptide repertoires in lupus.

Authors:  J J Wang; A D Colella; D Beroukas; T K Chataway; T P Gordon
Journal:  Clin Exp Immunol       Date:  2018-10-11       Impact factor: 4.330

Review 7.  New insights into the role of antinuclear antibodies in systemic lupus erythematosus.

Authors:  David S Pisetsky; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2020-09-03       Impact factor: 20.543

Review 8.  Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations.

Authors:  Sean Gavan; Ian Bruce; Katherine Payne
Journal:  Lupus Sci Med       Date:  2020-07

9.  The Utilization of Autoantibodies in Approaches to Precision Health.

Authors:  Marvin J Fritzler; Laura Martinez-Prat; May Y Choi; Michael Mahler
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

10.  Salivary anti-nuclear antibody (ANA) mirrors serum ANA in systemic lupus erythematosus.

Authors:  Ting Zhang; Yong Du; Qingqing Wu; Hao Li; Thao Nguyen; Gabriel Gidley; Valeria Duran; Daniel Goldman; Michelle Petri; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2022-01-03       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.